QT
TWST icon

Quantamental Technologies’s Twist Bioscience TWST Stock Holding History

Quantamental Technologies’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,439
Closed -$255K – 574
2023
Q2 		$255K Buy
+12,439
New +$186K 0.11% 329
2022
Q3 		– Sell
-11,310
Closed -$395K – 669
2022
Q2 		$395K Buy
+11,310
New +$401K 0.18% 214

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Quantamental Technologies's TWST Position: Q3 2023 in Review

Quantamental Technologies sold out of Twist Bioscience (TWST) in Q3 2023, closing a stake of 12,439 shares — an estimated $255K sold.

Quantamental Technologies first reported a position in TWST in Q2 2022 and held it in 2 quarters. The position peaked at $395K in Q2 2022. 195 funds tracked by Wall St. Rank hold TWST as of Q3 2023.

  • Quantamental Technologies reported no remaining Twist Bioscience position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 12,439 Twist Bioscience shares in Q3 2023, an estimated $255K.
  • Quantamental Technologies first reported a position in Twist Bioscience in Q2 2022 and held it in 2 quarters.
  • Quantamental Technologies's Twist Bioscience position peaked at $395K in Q2 2022.
  • 195 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.